24/120
1.0 / 5 stars
All 120 Win/Lose results shown below
KYMR Roast Me summary
Kymera Therapeutics, Inc. (KYMR). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinKYMR / S&P 37.68% / 15.20% |
WinKYMR / S&P 134.84% / 15.00% |
LoseKYMR / S&P KYMR unavailable / 50.40% |
| 2026-Q11/3 |
WinKYMR / S&P 7.04% / -4.33% |
LoseKYMR / S&P -12.58% / 11.30% |
LoseKYMR / S&P KYMR unavailable / 27.70% |
| 2025-Q41/3 |
WinKYMR / S&P 37.47% / 2.65% |
LoseKYMR / S&P -16.70% / 9.00% |
LoseKYMR / S&P KYMR unavailable / 13.40% |
| 2025-Q31/3 |
WinKYMR / S&P 29.70% / 8.12% |
LoseKYMR / S&P -50.05% / 4.61% |
LoseKYMR / S&P KYMR unavailable / 13.45% |
| 2025-Q21/3 |
WinKYMR / S&P 59.44% / 10.94% |
LoseKYMR / S&P -49.51% / 4.83% |
LoseKYMR / S&P KYMR unavailable / 10.63% |
| 2025-Q10/3 |
LoseKYMR / S&P -31.97% / -4.27% |
LoseKYMR / S&P -25.85% / 4.98% |
LoseKYMR / S&P KYMR unavailable / 10.57% |
| 2024-Q40/3 |
LoseKYMR / S&P -15.00% / 2.41% |
LoseKYMR / S&P -40.11% / 5.25% |
LoseKYMR / S&P KYMR unavailable / 6.15% |
| 2024-Q32/3 |
WinKYMR / S&P 58.56% / 5.89% |
WinKYMR / S&P 86.92% / 5.89% |
LoseKYMR / S&P KYMR unavailable / 6.11% |
| 2024-Q21/3 |
LoseKYMR / S&P -25.75% / 4.28% |
WinKYMR / S&P 71.38% / 5.38% |
LoseKYMR / S&P KYMR unavailable / 5.12% |
| 2024-Q12/3 |
WinKYMR / S&P 57.89% / 10.56% |
WinKYMR / S&P 70.16% / 5.71% |
LoseKYMR / S&P KYMR unavailable / 5.59% |
| 2023-Q42/3 |
WinKYMR / S&P 83.17% / 11.69% |
WinKYMR / S&P 67.84% / 6.81% |
LoseKYMR / S&P KYMR unavailable / 7.78% |
| 2023-Q30/3 |
LoseKYMR / S&P -39.54% / -3.27% |
LoseKYMR / S&P 1.92% / 7.52% |
LoseKYMR / S&P KYMR unavailable / -5.03% |
| 2023-Q20/3 |
LoseKYMR / S&P -22.41% / 8.74% |
LoseKYMR / S&P -8.95% / 9.50% |
LoseKYMR / S&P KYMR unavailable / -8.57% |
| 2023-Q11/3 |
WinKYMR / S&P 18.71% / 7.50% |
LoseKYMR / S&P -26.79% / 10.77% |
LoseKYMR / S&P KYMR unavailable / -15.69% |
| 2022-Q41/3 |
WinKYMR / S&P 14.65% / 7.56% |
LoseKYMR / S&P -35.71% / 11.88% |
LoseKYMR / S&P KYMR unavailable / -17.99% |
| 2022-Q31/3 |
WinKYMR / S&P 10.56% / -4.88% |
LoseKYMR / S&P -34.66% / 13.47% |
LoseKYMR / S&P KYMR unavailable / -1.41% |
| 2022-Q20/3 |
LoseKYMR / S&P -53.47% / -16.10% |
LoseKYMR / S&P -12.07% / 13.71% |
LoseKYMR / S&P KYMR unavailable / 11.04% |
| 2022-Q11/3 |
LoseKYMR / S&P -33.34% / -4.60% |
WinKYMR / S&P 29.29% / 15.97% |
LoseKYMR / S&P KYMR unavailable / 42.23% |
| 2021-Q41/3 |
LoseKYMR / S&P 8.09% / 11.03% |
WinKYMR / S&P 114.00% / 15.00% |
LoseKYMR / S&P KYMR unavailable / 96.40% |
| 2021-Q32/3 |
WinKYMR / S&P 21.11% / 0.58% |
WinKYMR / S&P 204.75% / 10.77% |
LoseKYMR / S&P KYMR unavailable / 69.42% |
| 2021-Q22/3 |
WinKYMR / S&P 24.81% / 8.55% |
WinKYMR / S&P 579.43% / 6.58% |
LoseKYMR / S&P KYMR unavailable / 51.81% |
| 2021-Q10/3 |
LoseKYMR / S&P -37.32% / 6.17% |
LoseKYMR / S&P KYMR unavailable / -1.06% |
LoseKYMR / S&P KYMR unavailable / 7.39% |
| 2020-Q42/3 |
WinKYMR / S&P 91.89% / 12.15% |
WinKYMR / S&P 1059.99% / -3.72% |
LoseKYMR / S&P KYMR unavailable / -33.42% |
| 2020-Q30/3 |
LoseKYMR / S&P KYMR unavailable / 8.93% |
LoseKYMR / S&P KYMR unavailable / -2.04% |
LoseKYMR / S&P KYMR unavailable / -27.10% |
| 2020-Q20/3 |
LoseKYMR / S&P KYMR unavailable / 20.54% |
LoseKYMR / S&P KYMR unavailable / -0.46% |
LoseKYMR / S&P KYMR unavailable / -27.11% |
| 2020-Q10/3 |
LoseKYMR / S&P KYMR unavailable / -19.60% |
LoseKYMR / S&P KYMR unavailable / 3.47% |
LoseKYMR / S&P KYMR unavailable / -14.75% |
| 2019-Q40/3 |
LoseKYMR / S&P KYMR unavailable / 9.07% |
LoseKYMR / S&P KYMR unavailable / 5.36% |
LoseKYMR / S&P KYMR unavailable / 2.99% |
| 2019-Q30/3 |
LoseKYMR / S&P KYMR unavailable / 1.70% |
LoseKYMR / S&P KYMR unavailable / 5.02% |
LoseKYMR / S&P KYMR unavailable / 0.21% |
| 2019-Q20/3 |
LoseKYMR / S&P KYMR unavailable / 4.30% |
LoseKYMR / S&P KYMR unavailable / 6.64% |
LoseKYMR / S&P KYMR unavailable / 8.65% |
| 2019-Q10/3 |
LoseKYMR / S&P KYMR unavailable / 13.65% |
LoseKYMR / S&P KYMR unavailable / 8.12% |
LoseKYMR / S&P KYMR unavailable / 14.29% |
| 2018-Q40/3 |
LoseKYMR / S&P KYMR unavailable / -13.52% |
LoseKYMR / S&P KYMR unavailable / 9.05% |
LoseKYMR / S&P KYMR unavailable / 18.23% |
| 2018-Q30/3 |
LoseKYMR / S&P KYMR unavailable / 7.71% |
LoseKYMR / S&P KYMR unavailable / 10.21% |
LoseKYMR / S&P KYMR unavailable / 19.06% |
| 2018-Q20/3 |
LoseKYMR / S&P KYMR unavailable / 3.43% |
LoseKYMR / S&P KYMR unavailable / 9.03% |
LoseKYMR / S&P KYMR unavailable / 14.46% |
| 2018-Q10/3 |
LoseKYMR / S&P KYMR unavailable / -0.76% |
LoseKYMR / S&P KYMR unavailable / 7.68% |
LoseKYMR / S&P KYMR unavailable / 12.46% |
| 2017-Q40/3 |
LoseKYMR / S&P KYMR unavailable / 6.64% |
LoseKYMR / S&P KYMR unavailable / 7.03% |
LoseKYMR / S&P KYMR unavailable / 13.82% |
| 2017-Q30/3 |
LoseKYMR / S&P KYMR unavailable / 4.48% |
LoseKYMR / S&P KYMR unavailable / 5.68% |
LoseKYMR / S&P KYMR unavailable / 17.57% |
| 2017-Q20/3 |
LoseKYMR / S&P KYMR unavailable / 3.09% |
LoseKYMR / S&P KYMR unavailable / 4.83% |
LoseKYMR / S&P KYMR unavailable / 17.74% |
| 2017-Q10/3 |
LoseKYMR / S&P KYMR unavailable / 6.07% |
LoseKYMR / S&P KYMR unavailable / 3.67% |
LoseKYMR / S&P KYMR unavailable / 13.32% |
| 2016-Q40/3 |
LoseKYMR / S&P KYMR unavailable / 3.82% |
LoseKYMR / S&P KYMR unavailable / 2.09% |
LoseKYMR / S&P KYMR unavailable / 7.05% |
| 2016-Q30/3 |
LoseKYMR / S&P KYMR unavailable / 3.85% |
LoseKYMR / S&P KYMR unavailable / 0.20% |
LoseKYMR / S&P KYMR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | KYMR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 187.42% | 20.78% |
| Annualized return | 187.42% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | KYMR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 93.87% | 83.14% |
| Annualized return | 14.16% | 12.86% |
10Y · 2020-08-21 to 2026-08-28
| Metric | KYMR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 256.03% | 319.30% |
| Annualized return | 13.54% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |